Clinical Trials Browser

Phase 4 × INDUSTRY × plerixafor × Clear all

NCT01164475 2014-02-25

Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms

Phase 4 Completed

61 enrolled 19 charts

Lymphoma, Non-Hodgkin